About Us | Contact

Scott Randall Evans Investigator

Sports Medicine Uc San Diego Health Hillcrest - Hillcrest Med Ctr NPI1699894808
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$8,779.95
from 25 payments in the last 6 years

Total Cash or Cash Equivalent

$8,250.00
from 8 payments in the last 6 years

Total In-kind Items & Services

$529.95
from 17 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
05/06/2021 General (Non-Research) In-kind items and services Food and Beverage $18.49 Details
Payment from Teleflex LLC
Payment Record ID 826698447
05/04/2021 Research Cash or cash equivalent Drug $1350.00 Details
Payment from Takeda Pharmaceuticals U.S.A., Inc.
Paymment Research Study A PHASE 3, RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY COMPARING PONATINIB VERSUS IMATINIB, ADMINISTERED IN COMBINATION WITH REDUCED-INTENSITY CHEMOTHERAPY, IN PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ ALL)
Clinical Trials Gov ID NCT03589326
Payment Record ID 816644429
05/04/2021 Research Cash or cash equivalent Drug $1350.00 Details
Payment from Takeda Pharmaceuticals U.S.A., Inc.
Paymment Research Study A PHASE 3, RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY COMPARING PONATINIB VERSUS IMATINIB, ADMINISTERED IN COMBINATION WITH REDUCED-INTENSITY CHEMOTHERAPY, IN PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ ALL)
Clinical Trials Gov ID NCT03589326
Payment Record ID 816644419
06/04/2021 General (Non-Research) In-kind items and services Food and Beverage $22.31 Details
Payment from Novo Nordisk Inc
Payment Record ID 811376999
08/20/2021 General (Non-Research) In-kind items and services Food and Beverage $20.66 Details
Payment from GlaxoSmithKline, LLC.
Payment Record ID 802291679
09/28/2020 Research Cash or cash equivalent Drug $1350.00 Details
Payment from Takeda Pharmaceuticals U.S.A., Inc.
Paymment Research Study A PHASE 3, RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY COMPARING PONATINIB VERSUS IMATINIB, ADMINISTERED IN COMBINATION WITH REDUCED-INTENSITY CHEMOTHERAPY, IN PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ ALL)
Clinical Trials Gov ID NCT03589326
Payment Record ID 737058789
09/25/2020 General (Non-Research) In-kind items and services Food and Beverage $22.05 Details
Payment from Allergan, Inc.
Payment Record ID 723860059
12/22/2019 General (Non-Research) In-kind items and services Food and Beverage $1.50 Details
Payment from DePuy Synthes Sales Inc.
Payment Record ID 708390349
03/19/2019 General (Non-Research) In-kind items and services Food and Beverage $13.92 Details
Payment from Teva Pharmaceuticals USA, Inc.
Payment Record ID 697708877
07/01/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $800.00 Details
Payment from Alexion Pharmaceuticals, Inc.
Payment Record ID 695579753
02/15/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $800.00 Details
Payment from Alexion Pharmaceuticals, Inc.
Payment Record ID 695579749
10/04/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $600.00 Details
Payment from Alexion Pharmaceuticals, Inc.
Payment Record ID 695579745
02/15/2019 Research Cash or cash equivalent Drug $800.00 Details
Payment from Alexion Pharmaceuticals, Inc.
Paymment Research Study Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Nave Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome aHUS
Clinical Trials Gov ID NCT02949128
Payment Record ID 692414001
08/29/2019 General (Non-Research) In-kind items and services Food and Beverage $22.56 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 658560891
08/15/2019 General (Non-Research) In-kind items and services Food and Beverage $14.16 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 658560876
08/05/2019 General (Non-Research) In-kind items and services Food and Beverage $14.25 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 658560845
07/15/2019 General (Non-Research) In-kind items and services Food and Beverage $15.45 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 658560811
01/11/2019 General (Non-Research) In-kind items and services Food and Beverage $32.31 Details
Payment from DePuy Synthes Sales Inc.
Payment Record ID 648753343
04/30/2018 General (Non-Research) In-kind items and services Food and Beverage $23.64 Details
Payment from GlaxoSmithKline, LLC.
Payment Record ID 594494437
08/24/2018 General (Non-Research) Cash or cash equivalent Consulting Fee $1200.00 Details
Payment from Alexion Pharmaceuticals, Inc.
Payment Record ID 569311960
08/06/2018 General (Non-Research) In-kind items and services Food and Beverage $26.36 Details
Payment from DePuy Synthes Sales Inc.
Payment Record ID 551683713
01/08/2016 General (Non-Research) In-kind items and services Food and Beverage $14.31 Details
Payment from GlaxoSmithKline, LLC.
Payment Record ID 396959331
08/31/2016 General (Non-Research) In-kind items and services Food and Beverage $122.46 Details
Payment from Novo Nordisk Inc
Payment Record ID 392162620
05/05/2016 General (Non-Research) In-kind items and services Food and Beverage $123.20 Details
Payment from Amgen Inc.
Payment Record ID 391198877
08/24/2016 General (Non-Research) In-kind items and services Food and Beverage $22.32 Details
Payment from HOLOGIC INC
Payment Record ID 370437130
;